Business
Why the CSL (ASX:CSL) share price has rebounded 13% since March
The CSL Limited (ASX: CSL) share price has been rebounding lately after hitting a 52-week low of $242.00 on 9 March. Since then, the company has gained 12.95%, with CSL shares currently trading at $273.35.
The global biotech has been busy producing the AstraZeneca COVID-19 vaccine while attempting to combat plasma collection concerns. Could this be the catalyst for its recent share price rise?
What’s driving the CSL share price higher?
Investors appear upbeat about the company’s progress to address its current issues as well as its attempts to open up new opportunities.
As announced on 14 April, CSL has been focused on increasing its plasma-protein production through its launch of a global challenge. The company is inviting…
-
Noosa News15 hours agoLuxury caravan manufacturer Zone RV collapses into administration
-
General16 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
General22 hours agoGold Coast warned it faces traffic gridlock without major shift to public transport
-
General24 hours agoF1 standings: Lando Norris, Max Verstappen, Oscar Piastri set for Abu Dhabi decider after Qatar GP